All
Test May Predict Breast Cancer Recurrence Risk, Chemotherapy Benefit
For patients with HR+, HER2- early breast cancer, MammaPrint may predict distant recurrence-free interval prognosis and chemotherapy benefit.
LiveLung Pittsburgh Hosts Music Therapy Presentation for Lung Cancer Community
LiveLung invites the Pittsburgh community to its monthly educational meeting.
FDA Fast Tracks Vaccine For Some With Breast Cancer
The FDA has granted fast track designation to the cancer vaccine GLSI-100 for patients with HLA-A*02-positive and HER2-positive breast cancer.
What Patients With Lung Cancer Need to Know About EGFR PACC Mutations
CURE spoke with Dr. Xiuning Le during the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer.
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
The FDA has approved Inlexzo for adults with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ.
Change of Season Musings As A Breast Cancer Survivor
When I think of fall, my mind jumps to when I had to wear furry hats because I’d lost my hair from chemotherapy.
Lunsumio plus Polivy Associated With Responses in MCL
For patients with relapsed/refractory mantle cell lymphoma Lunsumio plus Polivy was associated with durable responses.
Standing Up to Cancer with Lynch Syndrome
What does standing up to cancer mean to me? It means showing up for my life, even knowing that cancer is not a distant possibility but a biological reality.
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC
Patients with advanced, pretreated ROS1-positive NSCLC treated with zidesamtinib saw an objective response rate of 44%.
Rybrevant Plus Lazcluze Associated with Survival Improvement in NSCLC
For some with previously untreated locally advanced or metastatic non-small cell lung cancer Rybrevant plus Lazcluze improved overall survival.
Suleika Jaouad on Why Self-Advocacy Matters for Patients With Cancer
CURE spoke with the patient advocate and author of “Between Two Kingdoms” and “The Book of Alchemy.”
The Seasons of Cancer
The symbolism of seasons helped me to put some challenges of my cancer journey into perspective.
What Patients With Lung Cancer Need to Know About KRAS G12C Mutations
CURE spoke with Dr. Alexander Spira to learn what patients need to know about the KRAS G12C mutation and its treatment strategies.
Ivonescimab Plus Chemo Delays NSCLC Progression
In patients with EGFR-mutated NSCLC ivonescimab plus chemotherapy was associated with significant progression-free survival.
Standing Up to Cancer on My Own Two Feet
Thoughts on standing up to cancer through recovered mobility and by sharing my multiple myeloma journey.
FLAURA2 Shows Tagrisso Plus Chemo Boosts Survival in EGFR+ Lung Cancer
Dr. Eric Singhi sat down with CURE to break down the findings from the phase 3 FLAURA2 study, presented at the 2025 IASLC World Conference on Lung Cancer.
FDA Grants Orphan Drug Designation to BA-101 in Glioblastoma
The FDA has granted orphan drug designation to the investigational therapy BA-101 for the treatment of patients with glioblastoma.
Ifinatamab Deruxtecan Shows Activity in Previously Treated ES-SCLC
Dr. Myung-Ju Ahn shared notable data on ifinatamab deruxtecan for patients with previously treated extensive-stage small cell lung cancer.
Tagrisso With Chemotherapy Improves Survival in EGFR+ NSCLC
People with EGFR+ NSCLC whose disease spread outside the brain after treatment with Tagrisso lived longer when they kept taking Tagrisso along with chemo.
Iza-bren Plus Tagrisso May Offer a New Option for Advanced Lung Cancer
A combination of Iza-bren and Tagrisso showed beneficial results as an initial treatment for advanced/metastatic EGFR-mutated non–small cell lung cancer.
Dispelling Myths and Raising Awareness of Lung Cancer Risk
Never-smoker Leah Phillips, co-founder of the Young Lung Cancer Initiative, raises awareness that anyone with lungs can develop lung cancer.
Subcutaneous Darzalex Faspro Extends PFS in Smoldering Myeloma
Data from the AQUILA study support the use of fixed-duration subcutaneous Darzalex Faspro as an early treatment option in high-risk smoldering myeloma.
Venclexta And Azacitidine Fail to Improve MDS Survival
Results from the phase 3 VERONA trial were presented at the 2025 Society of Hematologic Oncology Annual Meeting.
What Does a Blood Cancer Diagnosis Mean?
Your diagnosis of an early-stage blood cancer, such as a MPN or MDS, means that something has changed in the way your bone marrow produces blood cells.
What Are Genitourinary Cancers, and How Are They Treated?
Here is an overview of cancers including bladder cancer, kidney cancer and testicular cancer.
Empower Yourself: What to Know After a Prostate Cancer Diagnosis
This comprehensive guide provides essential information to help patients and their families navigate their prostate cancer journey.
A Patient's Guide to Understanding Colorectal Cancer
Colorectal cancer is a complex disease. Understanding its fundamental aspects can empower you to have more informed and productive conversations with your oncologist.
FDA Grants Breakthrough Therapy to Olomorasib in Lung Cancer Subset
The FDA granted Breakthrough Therapy designation to olomorasib plus Keytruda for unresectable advanced or metastatic NSCLC with a KRAS G12C mutation.
Colorectal Cancer Screening Shifts as Cases Rise in Adults Under 50
Rising colorectal cancer rates in younger adults are prompting earlier screenings, with colonoscopy offering both detection and prevention.
Why Leaving a Breast Cancer Legacy Matters to Me
Leaving a legacy is essential for many, especially for those who have faced cancer. We long for our friends and family to understand how cancer impacts our lives.
